跳至主要内容
临床试验/CTRI/2024/06/069674
CTRI/2024/06/069674尚未招募不适用

The naive use of Histoglob in VKC- a pilot study

Sankara Eye Hospital1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2024年7月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
15
试验地点
1
主要终点
The primary outcome is to check how much reduction in the steroid dependence occurs as a result of intervention of this injection.

研究概览

简要总结

Background: Vernal Keratoconjunctivitis is a chronic inflammation of the conjunctiva affecting predominantly children in developing, hot and humid conditions, especialy spring season and it sometimes persists throughout the year. Patients are exposed to longer use of topical steroids to contain the inflammation but in turn, which has a drastic impact leading to steroid induced glaucoma which is a matter of concern younger population loosing sight.

Purpose: To address this loss (steroid induced glaucom/cataract) should not happen due to longer use of topical steroids, we thought of doing research alternatives in the best interest of the visual health of the patients of Vernal Keratoconjuctivitis (VKC)  by using Inj Histoglob in such patients in our pilot study

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
5.00 Year(s) 至 20.00 Year(s)(—)
性别
All

入选标准

  • Subjects with newly diagnosed and recurrent allergic eye diseases.

排除标准

  • Symptomatic patients of less than 6 months duration.

结局指标

主要结局

The primary outcome is to check how much reduction in the steroid dependence occurs as a result of intervention of this injection.

时间窗: The outcomes will be assessed and compared as baseline, week 1, 2 and 3 post injection.

次要结局

  • Minimising the steroid induced complications like glaucoma and cataract(To bring down the cost of treatment)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验